These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Tacke J; Mahnken A; Bücker A; Rohde D; Günther RW Rofo; 2001 Nov; 173(11):980-3. PubMed ID: 11704906 [TBL] [Abstract][Full Text] [Related]
31. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. Raman JD; Stern JM; Zeltser I; Kabbani W; Cadeddu JA J Urol; 2008 Jun; 179(6):2142-5. PubMed ID: 18423723 [TBL] [Abstract][Full Text] [Related]
34. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer. Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989 [TBL] [Abstract][Full Text] [Related]
35. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection. Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086 [TBL] [Abstract][Full Text] [Related]
36. Current status of renal radiofrequency ablation. Carraway WA; Raman JD; Cadeddu JA Curr Opin Urol; 2009 Mar; 19(2):143-7. PubMed ID: 19188768 [TBL] [Abstract][Full Text] [Related]